The 3 Best Big Pharma Dividend Stocks of the Past 10 Years
Big pharma's been in a funk over the recent past with the patent cliff and the recession, but these three stocks have delivered for investors.
Is Eli Lilly's Dividend Safe?
Here's what you need to know about Eli Lilly's dividend in the wake of patent expiration on Cymbalta and Evista.
MannKind Corporation's Date With Destiny
Will MannKind's Afrezza get approved and compete with injected mealtime insulins from Eli Lilly and Novo Nordisk.